Cepheid Inc $38.06

down -0.64


21/8/2014 04:00 PM  |  NASDAQ : CPHD  
Industries : Electronics / Scientific & Technical Instruments
Get Trend Analysis Icon Get CPHD Trend Analysis - it has underperformed the S&P 500 by 12%

Partner Headlines

  1. UPDATE: ISI Group Upgrades Cepheid

    Benzinga
  2. CEPHEID

    IBD
  3. LinkedIn, TripAdvisor, Google: Top Manager's Ideas

    IBD
  4. Alexion Takes Off On Outlook

    IBD
  5. Three Medical Tech Names To Watch In Healthcare Space

    IBD
  6. Align Leads Three Top-Rated Medical Equipment Stocks

    IBD
  7. UPDATE: JMP Securities Initiates Coverage on Cepheid on Market Leader Position

    Benzinga
  8. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  9. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  10. UPDATE: ISI Group Downgrades Cepheid on Key Drivers Constraining Revenue ...

    Benzinga
  11. Benzinga's Top Downgrades

    Benzinga
  12. UPDATE: Bank of America Downgrades Cepheid on Fair Valuation

    Benzinga
  13. Benzinga's Top Downgrades

    Benzinga
  14. Cepheid Reports Xpert MTB/RIF Categorized 'Moderate Complexity' by FDA

    Benzinga
  15. Cepheid Announces Board of Directors Changes

    Benzinga
  16. Cepheid's Chlamydia and N. Gonorrhoeae Test Categorized 'Moderate Complexity' ...

    Benzinga
  17. Medtech Stocks Moving As Conference Makes Waves

    IBD
  18. Medtech Stocks Moving As Conference Makes Waves

    IBD
  19. Cepheid Offers Update on Xpert Test Availability, Sees Q4 Sales ~$92M vs ...

    Benzinga
  20. UPDATE: Piper Jaffray Downgrades Cepheid to Neutral, Lowers PT

    Benzinga
  21. Oppenheimer Holdings Reiterates Outperform Rating, $43 PT on Cepheid

    Benzinga
  22. Canaccord Genuity Reiterates Buy Rating, $50 PT on Cepheid

    Benzinga
  23. Cantor Fitzgerald Reiterates Hold Rating, $38 PT on Cepheid

    Benzinga
  24. US Stock Futures Down Ahead Of Economic Data

    Benzinga
  25. Stocks To Watch For December 28, 2012

    Benzinga
  26. UPDATE: Cepheid Wins FDA Clearance for Xpert CT/NG

    Benzinga
  27. UPDATE: Bank of America Initiates Cepheid at Buy on Prospects, Platform

    Benzinga
  28. Look At That Base: If You Can't Name It, Don't Buy It

    IBD
  29. UPDATE: Goldman Sachs Downgrades Cepheid to Neutral on Lack of Catalysts

    Benzinga
  30. Benzinga's Top Downgrades

    Benzinga
  31. Benzinga's Top Upgrades

    Benzinga
  32. CEPHEID Reports Operating Results (10-Q)

    GuruFocus
  33. UPDATE: Cantor Fitzgerald Maintains Cepheid at Hold on Analyst Day Takeaways

    Benzinga
  34. UPDATE: Canaccord Genuity Reiterates Cepheid at Buy with $50 PT Post Analyst ...

    Benzinga
  35. Goldman Sachs Reiterates Buy Rating, $46 PT on Cepheid

    Benzinga
  36. UPDATE: ISI Group Reduces PT to $30.50 on Cepheid Post Analyst Day

    Benzinga
  37. Benzinga Mid-Afternoon Market Update

    Benzinga
  38. Stock Futures Point to Higher Open with Yahoo (YHOO) and Hewlett-Packard ...

    MarketIntelligenceCenter
  39. Benzinga Mid-Day Market Update

    Benzinga
  40. Mid-Morning Market Update

    Benzinga
  41. UPDATE: ISI Group Reduces PT to $32.50 on Cepheid Following Negative Pre-Announcement

    Benzinga
  42. Benzinga's Top Initiations

    Benzinga
  43. A Peek Into The Market Before The Trading Starts

    Benzinga
  44. UPDATE: JP Morgan Initiates Cepheid at Overweight on Growth Outlook

    Benzinga
  45. Benzinga's Top Initiations

    Benzinga
  46. Technology Sector Wrap

    FoxBusiness
  47. Technology Sector Wrap

    FoxBusiness
  48. Technology Sector Wrap

    FoxBusiness
  49. Analyst Downgrades: Cepheid, Intuitive Surgical, and Travelzoo

    SchaeffersResearch
  50. Cepheid Down 20% on Weak Guidance

    Benzinga
Trading Center